Intravitreal connective tissue growth factor neutralizing antibody or bevacizumab alone or in combination for prevention of proliferative vitreoretinopathy in an experimental model

2021 ◽  
pp. 108622
Author(s):  
Narsis Daftarian ◽  
Omolbanin Baigy ◽  
Fatemeh Suri ◽  
Mozhgan Rezaei Kanavi ◽  
Sahar Balagholi ◽  
...  
Keyword(s):  
Growth Factor ◽  
Connective Tissue ◽  
Experimental Model ◽  
Connective Tissue Growth Factor ◽  
Proliferative Vitreoretinopathy ◽  
Neutralizing Antibody ◽  
Tissue Growth

Ocular Safety of Intravitreal Connective Tissue Growth Factor Neutralizing Antibody

2017 ◽  
Vol 42 (8) ◽  
pp. 1194-1201 ◽  
Author(s):  
Tahmineh Motevasseli ◽  
Narsis Daftarian ◽  
Mozhgan Rezaei Kanavi ◽  
Hamid Ahmadieh ◽  
Abouzar Bagheri ◽  
...  
Keyword(s):  
Growth Factor ◽  
Connective Tissue ◽  
Connective Tissue Growth Factor ◽  
Neutralizing Antibody ◽  
Tissue Growth ◽  
Ocular Safety

Identification of connective tissue growth factor as a hepatic negative acute phase protein

Hepatology ◽  
2009 ◽  
pp. NA-NA
Author(s):  
Ieva Peredniene ◽  
Eddy van de Leur ◽  
Birgit Lahme ◽  
Monika Siluschek ◽  
Axel M. Gressner ◽  
...  
Keyword(s):  
Growth Factor ◽  
Connective Tissue ◽  
Connective Tissue Growth Factor ◽  
Acute Phase ◽  
Acute Phase Protein ◽  
Tissue Growth ◽  
Phase Protein
Sign in / Sign up

Export Citation Format

Share Document